Show simple item record

dc.contributor.advisorCamp, Dianne
dc.contributor.advisorLoeffler, David
dc.contributor.authorYagiela, Heather R.
dc.date.accessioned2011-10-25T14:57:13Z
dc.date.available2011-10-25T14:57:13Z
dc.date.issued1999
dc.identifier.urihttp://hdl.handle.net/10920/23789
dc.descriptionvii, 26 p.en_US
dc.description.abstractParkinson's disease (PD) is a neurodegenerative disorder resulting from decreased levels of the neurotransmitter dopamine. Patients with the disease suffer from muscle rigidity, tremors and balance impairment due to this loss. In order to counter the depletion of dopamine, the drug levodopa is commonly prescribed. However, some studies suggest that levodopa therapy promotes the production of free radicals in the brain, resulting in cellular damage due to oxidative stress. We believe that prolonged levodopa treatment does not result in oxidative stress. Using an animal model of PD with a unilateral 6-hydroxydopamine lesion, we administered carbidopallevodopa (5 mg/kg and 50 mg/kg, respectively) by intraperitonal injection for 17 consecutive days. An apomorphine screen was used to select animal subjects with a 90% or greater dopamine loss. Prior to the extraction of the striatum, ventral midbrain and cerebellum tissue, each animal received an i.p. injection of salicylate. Salicylate reacts with the free radicals of the brain producing dihydroxybenzoic acid (DHBA) in the form of 2,3-DHBA, whose level was measured using a high performance liquid chromatography system. The 2,3-DHBA to salicylate ratio was used to estimate hydroxyl radical production. No statistical difference was found in the 2,3-DHBA to salicylate ratios in any of the brain regions examined. These results suggest that repeated administration of levodopa does not promote the formation of free radicals in the brain and thus does not cause oxidative stress. This study implies that levodopa therapy is not hazardous to the health of patients and can be employed to treat the disease as deemed necessary.en_US
dc.description.sponsorshipClinical Neuroscience Laboratory. Sinai Hospital. Detroit, Michigan.
dc.format.mimetypeapplication/pdf
dc.language.isoen_USen_US
dc.publisherKalamazoo Collegeen_US
dc.relation.ispartofKalamazoo College Biology Senior Individualized Projects Collection
dc.relation.ispartofseriesSenior Individualized Projects. Biology;
dc.rightsU.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.
dc.titleEffects of Repeated Levodopa Administration in an Animal Model of Parkinson's Disease: A Study of Oxidative Stressen_US
dc.typeThesisen_US
KCollege.Access.ContactIf you are not a current Kalamazoo College student, faculty, or staff member, email dspace@kzoo.edu to request access to this thesis.


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Biology Senior Individualized Projects [1489]
    This collection includes Senior Individualized Projects (SIP's) completed in the Biology Department. Abstracts are generally available to the public, but PDF files are available only to current Kalamazoo College students, faculty, and staff.

Show simple item record